Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

被引：27
|
作者：
Huiberts, Anne J. [1 ]
de Gier, Brechje [1 ]
Hoeve, Christina E. [1 ]
de Melker, Hester E. [1 ]
Hahne, Susan J. M. [1 ]
den Hartog, Gerco [1 ,2 ]
van de Wijgert, Janneke H. H. M. [1 ,3 ]
van den Hof, Susan [1 ]
Knol, Mirjam J. [1 ]
机构：
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
[2] Radboudumc, Radboud Ctr Infect Dis, Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
EUROSURVEILLANCE | 2023年 / 28卷 / 07期
关键词：
D O I：
10.2807/1560-7917.ES.2023.28.7.2300087
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We used data of 32,542 prospective cohort study participants who previously received primary and one or two monovalent booster COVID-19 vaccinations. Between 26 September and 19 December 2022, relative effectiveness of bivalent original/Omicron BA.1 vaccination against self-reported Omicron SARS-CoV-2 infection was 31% in 18- 59-year-olds and 14% in 60- 85-year-olds. Protection of Omicron infection was higher than of bivalent vaccination without prior infection. Although bivalent booster vaccination increases protection against COVID- 19 hospitalisations, we found limited added benefit in preventing SARS-CoV-2 infection.
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
    Wei, Jia
    Matthews, Philippa
    Stoesser, Nicole
    Newton, John
    Diamond, Ian
    Studley, Ruth
    Taylor, Nick
    Bell, John
    Farrar, Jeremy
    Kolenchery, Jaison
    Marsden, Brian
    Hoosdally, Sarah
    Jones, E. Yvonne
    Stuart, David
    Crook, Derrick
    Peto, Tim E. A. I.
    Walker, A. Sarah
    Pouwels, Koen
    Eyre, David
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
    Jia Wei
    Philippa C. Matthews
    Nicole Stoesser
    John N. Newton
    Ian Diamond
    Ruth Studley
    Nick Taylor
    John I. Bell
    Jeremy Farrar
    Jaison Kolenchery
    Brian D. Marsden
    Sarah Hoosdally
    E. Yvonne Jones
    David I. Stuart
    Derrick W. Crook
    Tim E. A. Peto
    A. Sarah Walker
    Koen B. Pouwels
    David W. Eyre
    Nature Communications, 14
  • [33] Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
    Perez-Alos, Laura
    Hansen, Cecilie Bo
    Armenteros, Jose Juan Almagro
    Madsen, Johannes Roth
    Heftdal, Line Dam
    Hasselbalch, Rasmus Bo
    Pries-Heje, Mia Marie
    Bayarri-Olmos, Rafael
    Jarlhelt, Ida
    Hamm, Sebastian Rask
    Moller, Dina Leth
    Sorensen, Erik
    Ostrowski, Sisse Rye
    Frikke-Schmidt, Ruth
    Hilsted, Linda Maria
    Bundgaard, Henning
    Nielsen, Susanne Dam
    Iversen, Kasper Karmark
    Garred, Peter
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [34] Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
    Laura Pérez-Alós
    Cecilie Bo Hansen
    Jose Juan Almagro Armenteros
    Johannes Roth Madsen
    Line Dam Heftdal
    Rasmus Bo Hasselbalch
    Mia Marie Pries-Heje
    Rafael Bayarri-Olmos
    Ida Jarlhelt
    Sebastian Rask Hamm
    Dina Leth Møller
    Erik Sørensen
    Sisse Rye Ostrowski
    Ruth Frikke-Schmidt
    Linda Maria Hilsted
    Henning Bundgaard
    Susanne Dam Nielsen
    Kasper Karmark Iversen
    Peter Garred
    Nature Communications, 14
  • [35] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
    Gruell, Henning
    Vanshylla, Kanika
    Tober-Lau, Pinkus
    Hillus, David
    Schommers, Philipp
    Lehmann, Clara
    Kurth, Florian
    Sander, Leif E.
    Klein, Florian
    NATURE MEDICINE, 2022, 28 (03) : 477 - +
  • [36] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
    Henning Gruell
    Kanika Vanshylla
    Pinkus Tober-Lau
    David Hillus
    Philipp Schommers
    Clara Lehmann
    Florian Kurth
    Leif E. Sander
    Florian Klein
    Nature Medicine, 2022, 28 : 477 - 480
  • [37] Second SARS-CoV-2 Booster Vaccination Significantly Reduces Haemodialysis Patients' Susceptibility to Infection With Omicron Variant
    Wall, Nadezhda
    Banham, Gemma D.
    Casey, Anna L.
    Richter, Alex
    Cunningham, Adam F.
    Harper, Lorraine
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 314 - 314
  • [38] Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
    Kuhlmann, Constanze
    Mayer, Carla Konstanze
    Claassen, Mathilda
    Maponga, Tongai
    Burgers, Wendy A.
    Keeton, Roanne
    Riou, Catherine
    Sutherland, Andrew D.
    Suliman, Tasnim
    Shaw, Megan L.
    Preiser, Wolfgang
    LANCET, 2022, 399 (10325): : 625 - 626
  • [39] Mucosal IgA against SARS-CoV-2 Omicron Infection
    Zuo, Fanglei
    Marcotte, Harold
    Hammarstrom, Lennart
    Pan-Hammarstrom, Qiang
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (21):
  • [40] Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
    Li, Jianglong
    Liu, Qi
    Liu, Jun
    Fang, Zihui
    Luo, Liping
    Li, Shuang
    Lei, Yixin
    Li, Zhi
    Jin, Jing
    Xie, Ronglin
    Peng, Yucai
    VACCINES, 2022, 10 (11)
12345